MedQuist nets Anthelio contract

MedQuist Holdings, a provider of integrated healthcare clinical documentation tools, has been awarded a contract by Anthelio Healthcare Solutions of Dallas to implement MedQuist’s DocQment Enterprise Platform (DEP) speech recognition and clinical documentation in eight Anthelio client hospitals across five states for use by its medical transcriptionists.

DEP will replace existing technology currently in use by Anthelio, a health IT service provider, to assist efficiency and productivity through an automated clinical workflow management, the Franklin, Tenn.-based MedQuist stated.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.